India Pharma PE and VC Funding Rises 2.1x to $731M in 5 Years, Driven by AI Drug Discovery

According to BCG and HealthKois in a July 15 report, private equity and venture capital investment in India's pharmaceutical sector rose 2.1x over five years to US$731 million in FY26. The growth was driven by investment in AI-enabled drug discovery, advanced therapeutics, and platform technologies.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments